AGT and chronic kidney disease: Further, IS and angiotensin II exert a synergistic effect, thereby increasing EGFR expression in VSMCs, enhancing cell migration and the activity of extracellular signal-regulated kinases (ERK) [44], and potentiating artery atherosclerosis in CKD patients.